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Abstract
Background: Research translation, particularly in the biomedical area, is often discussed but there are few methods
that are routinely used to measure it or its impact. Of the impact measurement methods that are used, most aim to
provide accountability – to measure and explain what was generated as a consequence of funding research. This
case study reports on the development of a novel, conceptual framework that goes beyond measurement. The
Framework To Assess the Impact from Translational health research, or FAIT, is a platform designed to prospectively
measure and encourage research translation and research impact. A key assumption underpinning FAIT is that
research translation is a prerequisite for research impact.
Methods: The research impact literature was mined to understand the range of existing frameworks and
techniques employed to measure and encourage research translation and research impact. This review provided
insights for the development of a FAIT prototype. A Steering Committee oversaw the project and provided the
feedback that was used to refine FAIT.
Results: The outcome of the case study was the conceptual framework, FAIT, which is based on a modified
program logic model and a hybrid of three proven methodologies for measuring research impact, namely a
modified Payback method, social return on investment, and case studies or narratives of the process by which
research translates and generates impact.
Conclusion: As funders increasingly seek to understand the return on their research investments, the routine
measurement of research translation and research impact is likely to become mandatory rather than optional.
Measurement of research impact on its own is insufficient. There should also be a mechanism attached to
measurement that encourages research translation and impact – FAIT was designed for this task.
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Performance monitoring and feedback
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Background
It is an unfortunate reality that a substantial amount of
effective research does not translate, is not implemented
and does not create impact [1]. Grimshaw et al. [2] and
others note that, despite extensive investments in re-
search and development, relevant research findings are
not being fully implemented by healthcare systems and
are not being appropriately used by others in the chain
of scientific research [2–8]. The implication from sub-
optimal levels of research translation is that the return
on research investments is also lower than it could po-
tentially be. Despite awareness of this problem, the mis-
alignment between the generation of research outcomes
and the use, or application, of those outcomes is not be-
ing adequately addressed [9].
This study reports on the development of a frame-
work, referred to as the Framework to Assess the Impact
from Translational health research (FAIT), designed to
both measure and encourage research translation and
research impact. The novelty of this framework, and
what it adds to the impact measurement field, is that it
is designed to do more than provide a mechanism for
demonstrating accountability from funded research,
which is often the aim of impact measurement frame-
works. Our framework was designed with the explicit
aim of encouraging specific activities and behaviours as-
sociated with research translation. The underlying as-
sumption is that research translation is a prerequisite for
future research impact. The impetus for developing this
framework, by researchers affiliated with the Hunter
Medical Research Institute (HMRI), stemmed from an
aspiration to both demonstrate and optimise research
translation and impact.
We use two terms throughout this article: ‘research
translation’ and ‘research impact’ and have defined how
we use them.
Research translation
We developed this working definition because there
are many terms in the literature to define the process
of translating research-generated knowledge to others
[10–13]. Our working definition is:
…Research translation is a process of knowledge
generation and transfer that enables those utilising the
developed knowledge to apply it. This definition
acknowledges that, once generated, knowledge flows
can be multidirectional and non-sequential.
This definition recognises four core aspects of research
translation that FAIT would need to support. Firstly, that
research translation involves a stage of knowledge gener-
ation, for example, new insights generated from clinical
trials. Secondly, that it requires the generated knowledge
to be passed-on or shared. Thirdly, that knowledge shar-
ing provides an opportunity to apply the new information.
Finally, that the flow of knowledge is multidirectional and
non-sequential.
Research impact
As with ‘research translation’ the literature contains many
meanings of the term ‘research impact’ [14]. The working
definition for ‘research impact’, tailored for health and
medical research, is:
…the demonstrable effect from the flows of knowledge
between basic, patient and population-orientated
research, and clinical trials, that improves human
health and quality of life, and generates benefits for
the economy, society, culture, national security,
public policy, or the environment.
This definition recognises the contributions made
across the science spectrum and places prominence on
human health and quality of life. It includes flow-on
effects, such as increased productivity, reduced waste,
and contributions to economic growth, as well as trad-
itional academic outcomes. The measurement of what is
herein referred to as ‘research impact’ is based on this
definition.
The objectives guiding this case study were to (1) use
the existing literature to understand the range of meas-
urement frameworks and techniques relevant to measur-
ing and encouraging research impact; (2) design a
prototype framework capable of measuring and encour-
aging both research translation and research impact; and
(3) to refine the framework with input from a Steering
Committee.
Methods
This study was a pragmatic response by researchers at
HMRI to tackle the disparity between the creation of re-
search outputs and the uptake of those outputs. As an
organisation, HMRI has a number of attributes which
influenced this study; firstly, HMRI researchers work
across the spectrum of health and medical research from
basic to applied science. Secondly, the organisation par-
ticipates in research across a diverse range of diseases
and health services. Thirdly, the organisation has signifi-
cant engagement with a patient communities, heath
policymakers and the healthcare industry as well as aca-
demic and clinical researchers. Finally, HMRI is a facili-
tator of health and medical research as well as being a
funder of this research.
The study was based on a mixed methods approach
and involved the following: (1) a scoping review of exist-
ing research impact frameworks and techniques, which
served as the basis for the development of FAIT; (2) a
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development stage to design the prototype of FAIT; and
(3) a feedback stage where iterations of the evolving
FAIT were presented to our Steering Committee with
the aim of eliciting views and suggestions on how it
could be improved.
Objective 1 – Use the existing literature to understand
the range of measurement frameworks and techniques
that are relevant to measuring and encouraging research
translation and research impact
The objective of this scoping review was to identify the
range of frameworks and techniques used to measure
and encourage research translation and impact. This lit-
erature was then used as a platform to develop a proto-
type framework to measure and encourage research
impact.
The literature searches were conducted using NEW-
CAT+, available through the University of Newcastle li-
brary and limited to full text availability in English. This
search tool accesses journal articles listed in electronic
databases including OVID, Science Direct, Medline and
Econlit. Further literature searches were conducted
using references and citations from relevant papers. The
search was also conducted in Google scholar and Google
to identify literature from government departments,
international organisations and research funders with an
interest in the measurement of research translation and/
or research impact. These sites included the Australian
Research Council, National Health and Medical Re-
search Council, and WHO.
Search terms included ‘measuring research + (impact
or outcomes)’, ‘economic impact + (research or basic sci-
ence or applied science)’, and ‘measuring research im-
pact’. From the identified literature, further source
materials were identified using relevant references. Add-
itional references were also provided by reviewers of the
original version of this paper.
Impact assessment methods identified in the literature
were considered for our framework if they addressed
one or more of the following criteria: (1) generated a
result from measurement that would have meaning to
research funders; (2) facilitated communication of com-
plex translational processes; and (3) encouraged, or had
the potential to encourage, research translation and re-
search impact.
Objective 2 – Framework design and development
The design of FAIT was mostly conducted by health
economists at HMRI who examined the frameworks and
techniques found in the literature. The usefulness of this
information was guided by the aims guiding the design
of FAIT. These were to (1) capture processes, outcomes
and impacts generated across the spectrum of health re-
search from discovery to applied science; (2) encourage
research translation; (3) enable the implementation of
improvement processes when research translation fails;
(4) utilise cost-effective data collection techniques; and
(5) facilitate communication on research impact. Non-
economists were also involved in the design and develop-
ment of FAIT and were part of the Steering Committee
overseeing FAIT’s refinement.
Objective 3 – Framework refinement
Once the prototype framework was developed, stake-
holder feedback was collected from a project Steering
Committee whose membership represented research
funders, clinicians, basic science researchers, applied
science researchers, primary healthcare, and university
administration. Steering Committee members are in-
cluded in our authorship (AS, JA, DK, JW, JM, BW, SH
and MN).
The process involved successive presentations of FAIT,
in its various stages of development, to the Steering
Committee over 2014 and 2015. Feedback from each
presentation was considered by the economist authors
(AS and SD) and used, where appropriate, to refine
FAIT. This attempt at co-design aimed to ensure the
prototype of FAIT reflected the needs of a broad range
of end users. A national presentation on FAIT was also
made at the Australian National Health and Medical Re-
search Council’s Symposium on Research Translation
[15]. Comments received by the authors as a result of
this presentation were also included in the design.
Results
Objective 1 – The range of measurement frameworks and
techniques relevant to the measurement and
encouragement of research translation and research
impact
As numerous reviews have been conducted on frame-
works to measure research impact, our intention was
not to conduct another appraisal of this literature. In-
stead, our goal was to use the existing reviews to under-
stand the range of frameworks and the techniques
available to measure research translation and research
impact. As FAIT was to be designed to both measure
and encourage research translation and research impact,
additional techniques were also considered if they had a
potential to assist the ‘encouragement’ aspect of FAIT’s
design. A summary of information extracted from influ-
encing articles is provided below.
The systematic review by Banzi et al. [16] and a more
recent review by Milat et al. [17] provided the basis for
understanding the range of frameworks and techniques
from measuring research impact. More recent expansion
on this literature is provided by Greenhalgh et al. [18],
who report on existing methods to measure research im-
pact as well techniques that are under development.
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The measurement of research impact is a relatively
new field, and while the methods have been developing
since the 1990s [19], most activity in this space has
taken place since 2006 [17]. Banzi et al. [16] identified
broad categories of frameworks based on bibliometrics,
econometrics and ad hoc case studies. When considering
all available frameworks, the most frequently used
method was Payback, a finding confirmed by Banzi [16],
Milat [17] and Greenhalgh [18].
The study presented here focuses on three measure-
ment methods: Payback, economic evaluations, and case
studies. These methods meet most of the acceptance cri-
teria for this case study and they cover a broad spectrum
of impact assessment techniques, particularly because
Payback, or a derivation of Payback, is the basis of many
other impact measurement frameworks [18].
Payback
The Payback Framework, developed in the 1990s by
British researchers Buxton and Hanney [20], is the most
common method employed for measuring research im-
pact [15]. The method is based on the identification of
domains of benefit such as knowledge impacts, research
impacts, and political and policy impacts. Payback is
usually implemented through semi-structured interviews
to obtain the perspective of researchers as to the impact
of their research [17]. This information is supported by
bibliometric analysis and verification studies [17]. The
technique provides a scorecard on the payback to society
for investing in research and it is widely used in
Australia, the United Kingdom and Canada [16, 20–26].
Conceptually, Payback can be modified to be the basis of
a prospective measurement framework. It can also be
modified to populate the domains of benefit with quanti-
tative metrics [16], rather than qualitative interview data.
The Payback method is intuitive and the results pro-
vide a sense of the outputs and outcomes produced in
broad domains relevant to policymakers, funders and
the general community. However, while the Payback
methodology is well developed, it requires substantial re-
sources to implement. The labour intensity of imple-
menting Payback is a consequence of the combination
of researcher interviews, document analysis and valid-
ation work that feeds into the assessment. If measure-
ment becomes a disproportionate burden to the activity
being measured, there is a real risk it will not be under-
taken. This is one possible reason why the routine meas-
urement of research impact remains elusive [13]. It is
for this reason that some evaluators have modified the
Payback Framework to reduce resource intensity [18].
Economic measures
Economic measures for evaluation typically compare
cost against a measure of outcome; they often report
outcome measures expressed in monetary terms or rates
of return. For the purpose of measuring research transla-
tion and research impact, it is preferable that multiple
benefits be included. For this reason, out of the suite of
potential economic evaluation techniques, cost-benefit
analysis (CBA) stood out as being the appropriate tool.
Further, as costs and consequence are financial values,
the reportable metric of CBA is a ratio of benefit per
dollar of cost, or a ‘return on investment’. CBA is the
basis of a more encompassing Social Return On Invest-
ment (SROI) analysis, which takes a broader perspective
of the range of benefits captured and reported [27].
SROI is an appealing technique for evaluating health-re-
lated research because it allows the inclusion of flow-on
impacts from improved patient health such as improved
worker productivity. From a societal viewpoint, SROI re-
ports the return on investment where benefits include
public and private returns.
Although interesting on many levels, the economic ap-
proaches have drawbacks. One of these is that economic
modelling is frequently based upon simplifying assump-
tions [18], such as time lags between discovery and util-
isation, extent of uptake, and contentious monetised
values placed on some benefits. An example of the latter
would be a financial value applied to a given improve-
ment in ‘quality of life’. Despite these drawbacks, eco-
nomic approaches have been used in Australia to
provide estimates of the benefit from investments into
health and medical research [28–30] based on top-down
modelling approaches. These analyses made extensive
assumptions to estimate both attribution to a body of
research and the estimated benefits [18]. Bottom-up ap-
proaches can alleviate the attribution problem when,
for example, cost, cost-effectiveness, cost-utility, and
cost-benefit analyses are derived from data collected
from controlled trials. These data allow the evaluation
to be more precise in relating attribution to a new
intervention [18].
Case studies
The United Kingdom RAND organisation reviewed se-
lected frameworks to measure research impact and de-
termined that evidence-based case studies for measuring
impact were superior to quantitative metrics, even when
the case studies were prepared by the research leaders
being evaluated [31]. The strength of case studies is that
they provide a narrative of the often complex and bidir-
ectional knowledge flows. While case studies may rely
on expert advisory panels to review qualitative impact
statements [31], they are prone to the same biases that
characterise self-reports such as selective memory [16]
and, importantly, they cannot produce the quantitatively
based metric of ‘return on investment’. Further, the con-
struction of case studies tends to be resource intensive,
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reducing their viability for widespread and routine meas-
ure of research impact [16]. Nonetheless, case studies pro-
vide worthwhile contributions particularly by describing
the often complex pathways for research translation.
These descriptions can be powerful tools for communicat-
ing the nature and extent of research translation and,
ultimately, research impact.
Other measurement approaches
Of the identified, alternative techniques for measuring
research impact, many were found to be modified or
adapted forms of Payback. For example, the Canadian
Academy of Health Sciences framework and the Re-
search Impact Framework; the latter was designed as a
checklist to encourage consideration of translational
processes [18]. Technological advancements in elec-
tronic databases have also opened new avenues to collect
and report data that can be used to conduct an impact
assessment [18]. For example, commercially available
electronic services (such as Researchfish®) collect data on
publications, citations and other ‘macro’ sources and
then combines this information with uploaded ‘micro’
data from research teams on collaborations, prizes, and
other outputs and outcomes [18].
Program logic models The construction of a program
logic model is often viewed as a formative methodo-
logical step in measuring research impact [18, 32]. They
are not measurement frameworks on their own, but they
provide the rationale linking the research aims and activ-
ities to research outputs, and from research outputs
through to anticipated impact [18, 33]. In their standard
form, these models provide a conceptual linkage be-
tween inputs, activities, outputs and impact [18]. Typic-
ally, these models are predictive; anticipating the outputs
and outcomes from research-generated knowledge.
In their basic form, the linear nature of program logic
models has been criticised as providing an over simplifi-
cation of the complex pathways observed in the lifecycle
of research development, transfer, utilisation and, ultim-
ately, impact [34]. A more fluid, and less linear, approach
would allow feedback loops between the different actors
in the research translation pathway [34]. It is also argued
that any predictive powers of program logic models will
be weakened if the research findings are unclear or simply
identify the extent of the problem, rather than providing
an evidence-based solution [34].
Performance frameworks Performance frameworks
were not typically found amongst the reviews of impact
measurement frameworks. While common reasons for
measuring research impact tend to focus on accountability
and advocacy [35–38], it is rare to find an impact meas-
urement framework where the purpose of measurement is
to explicitly encourage certain behaviours or activities. In-
sights from the quality improvement literature suggest a
reason why research impact frameworks could consider
aspects of performance monitoring and feedback. The use
of continuous quality improvement in health and other
fields, provides an evidence base for how it can modify
performance. A Cochrane review on this issue found posi-
tive effects through an ‘audit and feedback’ mechanism to
improve the performance of health professionals [39].
However, to improve performance or change behaviours,
measurement needs to occur within a framework that
links metrics to the process of improvement [40–42]. A
cautionary warning is that performance monitoring re-
quires careful metric selection to ensure the selected in-
centives drive the anticipated behaviour [43].
There are arguments against using such an approach
because of its resemblance to a prescriptive specification
sheet. Ward [44] argues a checklist of translational activ-
ities is a sub-optimal approach to increasing research
translation as its content would not reflect the complex
and multidirectional processes by which research trans-
lates. A more productive approach, would be for re-
searchers to understand the complexity of translational
process so that they can embed appropriate and tailored
translational interventions into their research [44].
Objective 2 – Framework design and development: a
conceptual model for measuring and encouraging
research translation and research impact
FAIT was the product of understanding the components
of research impact frameworks and was designed to
address the aims of (1) capturing processes, outcomes
and impacts generated across the spectrum of health
research from discovery to applied science; (2) encour-
aging research translation; (3) enabling the imple-
mentation of improvement processes when research
translation fails; (4) utilising cost-effective data collec-
tion techniques; and (5) facilitating communication on
research impact.
As a consequence of the ‘encouragement’ aim, FAIT is
designed to be prospective tool, implemented at the
start of a research program. FAIT is based on a modified
program logic model that guides the overall assessment,
three core methods (a modified Payback approach,
SROI and case studies), and uses a scorecard to report
results.
A modified program logic model
The modified program logic model identifies (1) the
need being addressed by the research program; (2) the
research activities being supplied to meet the ‘need’; (3)
the expected research outputs; (4) the end-users of those
research outputs; and (5) the anticipated impact from
the use of the research outputs. An advantage of this
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modification is that it identifies who will use the re-
search products, i.e. the ‘end-user’. For basic research,
the end-user might be other basic scientists or pharma-
ceutical companies interested in progressing the research,
and for population health research, the end-user might be
public health authorities.
The program logic model also can be used to tease out
anticipated research outputs (e.g. new guidelines). Fi-
nally, it provides a view on how the research is antici-
pated to generate impact – and the types of impact that
are expected. In our view, this information can guide the
selection of impact metrics.
We accept that linear program logic models fail to
replicate the complexity and ambiguities of the ‘research
to utilisation’ cycle. However, the models are meant to
be an approximation of the anticipated path for research
translation and subsequent impact, i.e. it is a guide ra-
ther than a replica of reality. Further, the construction of
the program logic model at the beginning of the re-
search program allows for incremental modifications to
its design over the life of the research program. That is,
the program logic model can change over time, as unex-
pected research outputs become evident, political influ-
ence is exerted or, for other reasons, the research takes a
different path to that originally planned. Figure 1 pre-
sents an example of a program logic model for an initia-
tive to reduce unnecessary emergency department
admissions from aged care facilities. The model links
community need for the intervention to the research
services that are being supplied in response to that need.
The logic model identifies research products and the
end-users who are expected to utilise these products.
The model also provides the range of anticipated im-
pacts from the research.
Three core methods incorporated into FAIT
While the program logic model provides an explanation
of the linkages from knowledge generation to utilisation,
three component methodologies provide the evidence to
demonstrate research translation and help quantify re-
search impact: a modified Payback approach, SROI and
case studies.
Fig. 1 Hypothetical example of a logic map for research addressing unnecessary emergency department presentations from residents in aged
care facilities
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Modifications to payback
(1)Domains of benefit
The first modification to Payback is to use the
domains of benefit recognised by the Becker List
[45] because of their inclusion of the domain of
‘Clinical implementation’, which is particularly
relevant to health and medical research. These
domains of benefit are shown in the far right hand
column in Fig. 1.
(2)Determine relevant metrics for measuring impact
The second modification is to incorporate metrics to
represent anticipated benefit or impact. These will
include universal measures that will be applicable
across the research spectrum, for example, metrics
for Advancement of Knowledge might include
publications and completed PhDs. Customised
metrics will also be included that are tailored to the
research program. Using metrics within each
domain is similar to that proposed by Banzi et al.
[16, 17] and initial work on possible metrics has
been published [45]. These metrics, combined with
prospective data collection, should minimise the need
for expensive and potentially less accurate retrospective
data collection. Some of the metrics will be structured
to support the planned economic analysis.
(3)Inclusion of process metrics
The third modification to Payback is to include a
module of process metrics – these are based on
performance monitoring and feedback principles,
and are separate to the measures of impact. They
are designed to provide regular feedback to research
leaders on key activities related to their research,
including activities associated with research
translation. Feedback allows research leaders/
managers to assess whether the implementation of
these activities is appropriate or whether they
require attention. The potential is to use process
metrics that support research translation activities
and behaviours so that (1) they are identified to
researchers and (2) their use is encouraged.
There is a developing body of work as what these
activities and behaviours might be [46–48]. For
example, activities such as early engagement with
end-users, the development of a strategic plan
explaining the translational pathway (e.g. a program
logic model), and an understanding of the barriers to
translation, have been shown to be associated with
successful research translation [2, 48]. Oliver et al.
[47] provide a list of facilitators and barriers to
research translation that could also be used as a
starting point. Others have investigated the length of
time research takes to translate and identified factors
that may be associated with accelerated uptake.
Hanney et al. [46] reported on the success of
economic incentives to get drugs to market once
Phase III trials were complete (and had demonstrated
success). We see the process metrics as having
flexibility so that researchers can also nominate
other translational activities that might be tailored
to their research.
SROI The second method adopted by FAIT is based on
an economic measure: SROI. The reporting of SROI
provides useful information on the return received by
society for investments into health-related research. This
simple ratio is expressed as the number of dollars of
community benefit per dollar of cost; it is well under-
stood by policymakers, research funders and the broader
community and allows direct comparison with SROI cal-
culated for other programs. SROI is a metric that can be
calculated using simulations, or projections, at the plan-
ning stage. These simulations can then be compared to
subsequent recalculations using actual data as the re-
search program progresses and delivers outputs.
The inclusion of project-based economic assessment
methods, such as SROI, has several benefits. First, the
methodical process of reviewing the research interven-
tion, the anticipated pathways to impact, and determin-
ation of where and for whom costs and benefits accrue,
serves to emphasise the key risks that need to be man-
aged to realise the anticipated benefits, for example, to
ensure effective implementation. The results of an eco-
nomic assessment can also enable comparison between
alternative interventions and provide evidence to address
potential budgetary hurdles to impact. In contrast to
top-down assessments, bottom-up economic analyses
provide greater project-specific detail and, consequently,
greater potential influence upon research activity. Eco-
nomic analyses that express the result as a simple and
widely understood ratio of ‘dollars of benefit per dollar
of cost’, can also provide a compelling supportive argu-
ment to policymakers and the wider community.
Case studies FAIT’s third method is based on case stud-
ies selected from the program of research. This intro-
duces a qualitative aspect to the measurement of
research impact and provided a narrative of how transla-
tion occurred and how research impact was generated.
The case studies are expected to be supported with evi-
dence extracted from the modified Payback and SROI.
Case studies enable quantitative findings to be placed in
context, and they are an opportunity to explain variances
in research costs, outputs and impacts.
Reporting the results: a scorecard
Combining the outcomes from these three methods pro-
vides a scorecard to report research impact; the content
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of the scorecard grows as the research progresses. The
scorecard (Figs. 2 and 3) is a summary of the outcomes
from the three methods and allows the outcomes to be
triangulated, strengthening the level of confidence in
claimed research impact. The content of the scorecard
will reflect where the research sits in its lifecycle. Newly
established research will have little to report, while com-
pleted research would be expected to have a more
complete scorecard.
The scorecard is designed to be a simple communica-
tion tool that contains top-level results for each of the
three component methods. To report results, FAIT will
express findings, where appropriate, with a common de-
nominator such as completed PhDs per $1 m of funding.
In practice, this will require a standardised research cost
base, based on the cost of undertaking research within a
specific country or geographic location.
The scorecard examples are taken from hypothetical
basic science and applied science situations. Figure 2
shows the scorecard for research into targeted therapy
for asthma patients. This scorecard represents an incom-
plete research program, early in its lifecycle, hence some
benefits and costs are ‘to be confirmed’. Projections have
identified potential cost savings to the health system, but
there is more information to be collected over the course
of the research to complete this scorecard. Figure 3 shows
as example of implementing a model of care in a study
population. At the point of providing this hypothetical
scorecard, the research has been shown to be effective in
the study population. It also shows the results from the
three component methodologies.
Objective 3 – Stakeholder inputs to FAIT
Stakeholder feedback was provided via our Steering
Committee. A number of issues with the early prototype
versions of the framework were identified. Stakeholders
focused on potential bias in measuring impact, potential
bias in the reporting of impact from different sized re-
search projects and how the measurement framework
would assist communication about the demonstration of
research impact. Another issue concerned the cost of
implementing FAIT.
First, stakeholders noted that the measurement of
impact could create a bias against research that has an
extended time between a research discovery being trans-
lated through to the point of use. This concern was ad-
dressed in two ways. First, the concerns reinforced the
appropriateness of a broad working definition for re-
search impact. A broad definition includes the conse-
quence of research that may not have a patient-level
impact, but generates an impact elsewhere such as con-
tributing to a body of knowledge. Second, SROI supports
scenario modelling, where the evidence available at given
time points is used to model future states with and
without (i.e. the counterfactual) specific research innova-
tions. As new evidence becomes available, the key as-
sumptions underpinning these modelled scenarios are
adjusted. In Australia, a similar scenario modelling exer-
cise is already required by one major research funder [49].
A further concern was how a research project’s size
would possibly influence the communication of research
impact. Larger research projects would be likely to have
more opportunities to generate impact (e.g. more capacity
opportunities through PhDs and post-doctoral positions)
the expectation was that they would appear more success-
ful than smaller research projects purely based on funding.
FAIT addresses this concern by reporting, where feasible,
the results as a function of a common standardised
denominator, for example, PhDs completed per $1 m
of funding.
‘Communication’ was raised in the context of the
benefit of FAIT to researchers in providing a research
translation and research impact narrative. This issue fo-
cused on the ability of FAIT to meet accountability ob-
jectives and assist researchers to demonstrate research
translation and research impact, which are increasingly
required for funding applications. Demonstration of
these concepts is a core component of FAIT. This issue
highlighted the need for a plainly written narrative
explaining the need the research addresses, what was
produced, and what impact was generated. Hence, the
inclusion of case studies is an important communication
mechanism.
The cost of implementing FAIT is yet to be deter-
mined. However, two Australian Centres of Research
Excellence, with funding to 2019, have committed to
implementing FAIT and this exercise will shed light on
the resources required for implementation.
Discussion
The purpose of this study was to develop a research im-
pact framework designed to measure and encourage re-
search translation and research impact. With a set of
clear goals, an understanding of the strengths and limi-
tations of existing impact frameworks, FAIT was devel-
oped and refined with the input of stakeholders. This
novel framework explicitly encourages activities that are
associated with research translation. It does this by in-
cluding performance monitoring and feedback that tar-
gets activities and behaviours associated with research
translation, with an underlying assumption that success-
ful research translation is a forerunner of research
impact.
Hence, the main strength in the application of FAIT is
not just to report the outcomes from funded research
but also to actively encourage researchers to consider re-
search translation activities. The body of evidence as to
what these activities might be is still developing, but
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Fig. 2 Hypothetical scorecard example – early stage basic science research
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Fig. 3 Hypothetical scorecard example – at completion of a clinical application of a model of care
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already several authors have identified factors that ap-
pear to be associated with research translation and the
generation of research impact (see Hanney et al. [46],
Oliver et al. [47] and Wooding et al. [48] for examples).
Some will disagree with a checklist approach. Ward [44]
argues that checklists for encouraging research transla-
tion are of limited value and that a better mechanism is
for researchers to understand the complexity of the
translational process and come up with their own be-
spoke translation activities. Acknowledging that research
teams may have resource constraints that limit their
ability to develop tailored plans, FAIT provides a check-
list of evidence-based translational activities but re-
searchers would be free to add to this list with tailored
translational activities and plans.
This study had a number of limitations. Foremost, is
that FAIT is a conceptual model and, as yet, untested.
Further, the measurement of research impact is not uni-
versally welcomed. Critics argue that measurement
could have unintended consequences by influencing the
direction of research funding with possible adverse effects
for blue-sky research [50], where applications for the re-
search outcome are not immediately apparent. However,
this problem is not insurmountable. With appropriate
time scales and measurement techniques, the prospective
measurement of research impact can include the conse-
quences from all research, regardless of whether that re-
search is targeted or blue-sky.
Common to all frameworks that aim to measure re-
search impact, including FAIT, are the following three
problems. First, without appropriate study designs it can
be difficult to identify causality – did the research cause
the impact? Second, it may be difficult to define the ex-
tent of attribution – whether the research accounted for
all or a small proportion of the impact. Many causes,
other than research-generated knowledge, may lead or
contribute to an impact. This problem is exacerbated by
communication and knowledge sharing, because re-
search and development is now globalised [33, 51]. This
worldwide sharing of knowledge makes it contentious to
exclude the contribution of global research outputs and
to claim a specific research project is fully responsible
for a particular impact. The third problem is timing; the
impact from research may take more than a decade to
materialise. Hanney et al. [46] identify instances where
impacts have taken several decades. Depending on the
point of measurement, the measurement of impact may
fail to capture as yet unrealised benefits [51]. This prob-
lem is typically thought to affect basic science discover-
ies, which might require decades before societal
measures of impact are recorded. Addressing this issue
would require ongoing updating with a need to gather
and report evidence of research translation and impact
as it unfolds. Additionally, simulation modelling can be
included within SROI where the best available evidence
is used to model future impact values.
The changing policy landscape, with respect to the
funding of health and medical research, is likely to see
increased use of frameworks such as FAIT. In many
countries, including Australia, the routine measurement
of research impact is becoming embedded across the
spectrum of research. The creation of the Australian
Government’s Medical Research Futures Fund and its
AU$20 billion investment to support health and medical
research, will ensure future funding will be partly insu-
lated from changes in the economic cycle. However, this
potential increase in security for research funding will be
met with heightened expectations that this public invest-
ment will deliver greater yields for the community. Key
Australian funders are in unison when it comes to
statements on the need to measure research impact and
increase collaboration and engagement between re-
searchers and end users. However, the need is not just to
measure research translation and research impact. The
need is for frameworks that incentivise and assist re-
searchers understand, plan for, and implement processes
to increase the likelihood of research translation. If re-
search translation is optimised, this increases the chance
for research-generated knowledge to generate impact.
The routine use of FAIT in the research community
will depend on its ability to provide relevant and robust
results and to do so efficiently; that is, to avoid undue
burden on researchers with regard to data collection, ana-
lysis and reporting. The next step is to evaluate FAIT in a
scientific setting and to collect evidence as to its ability to
encourage translational activities and behaviours, to assess
its effectiveness in reporting research impact, and to re-
port the resources it required for implementation.
Conclusions
FAIT is a mixed methods approach to encourage and
measure research translation and research impact. Its
novelty is to add a new aim for measurement activities
beyond accountability purposes, that is, to actively en-
courage research translation to optimise the likelihood
of research-generated knowledge being used and, hence,
generate impact. FAIT combines methods that bring differ-
ent perspectives to understanding and measuring research
impact. Supported by a program logic model, FAIT com-
bines quantitative and qualitative measurement tech-
niques, with the latter providing an opportunity to explain
complex bidirectional translational pathways. Embedded
within FAIT is a module for performance monitoring and
feedback with the goal of encouraging research translation.
The scorecard approach to reporting outcomes and impact
maintains simplicity and is a useful communication tool.
The inclusion of ‘return on investment’ is a metric that we
believe research funders will increasingly require.
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